Lessons Learned from Alternative Methods and their Validation for a New Toxicology in the 21st Century

Europe and the United States further the development of new toxicological tools in different ways. While the replacement of animal tests has been promoted strongly in Europe over the last decades (following the 3Rs principles—reduce, replace, refine), in the United States the vision for a toxicology in the 21st century (Tox-21c), which was prompted by the National Research Council document only 3 years ago, dominates the discussion. In both cases, there is significant political support. However, while in Europe the horizontal animal welfare legislation from 1986 (which urges the use of 3Rs methods wherever possible) currently under revision and cosmetics and chemical legislation are the primary drivers, in the United States it is mainly federal agencies, most prominently the U.S. Environmental Protection Agency (EPA), that made the implementation of the NRC report their toxicity testing strategy only in 2009. This preempts such likely legislative measures as the reauthorization of the Toxic Substances Control Act (TSCA) in the United States. The European implementation is characterized by substantial broad funding programs to develop 3Rs methods and can be termed a “bottom-up” approach; in contrast, the Tox-21 program represents a “top-down” approach, where programmed research is carried out and commissioned. It is postulated that the two approaches are two sides of the same coin, and instruct and complement each other. However, more importantly, if brought together they can result in a Human Toxicology Project and a real revolution in regulatory toxicology.

[1]  W. Russell,et al.  Ethical and Scientific Considerations Regarding Animal Testing and Research , 2011, PloS one.

[2]  T Hartung,et al.  The use of embryonic stem cells for regulatory developmental toxicity testing in vitro--the current status of test development. , 2004, Current pharmaceutical design.

[3]  Thomas Hartung,et al.  Food for thought... on animal tests. , 2008, ALTEX.

[4]  Valérie Zuang,et al.  A Modular Approach to the ECVAM Principles on Test Validity , 2004, Alternatives to laboratory animals : ATLA.

[5]  Steven K. Gibb Toxicity testing in the 21st century: a vision and a strategy. , 2008, Reproductive toxicology.

[6]  Thomas Hartung,et al.  Points of Reference in the Validation Process , 2008, Alternatives to laboratory animals : ATLA.

[7]  Raymond S. H. Yang Commentary: some critical issues and concerns related to research advances on the toxicology of chemical mixtures , 1998, Environmental Health Perspectives.

[8]  R D Combes,et al.  Early microdose drug studies in human volunteers can minimise animal testing: Proceedings of a workshop organised by Volunteers in Research and Testing. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[9]  M. Leist,et al.  Food for thought... on the real success of 3R approaches. , 2008, ALTEX.

[10]  Thomas Hartung,et al.  Optimisation of the Post-validation Process , 2008, Alternatives to laboratory animals : ATLA.

[11]  Michael Schwarz,et al.  The integrated project ReProTect: a novel approach in reproductive toxicity hazard assessment. , 2005, Reproductive toxicology.

[12]  Thomas Hartung,et al.  A Toxicology for the 21st Century—Mapping the Road Ahead , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[13]  Thomas Hartung,et al.  Re-evaluation of animal numbers and costs for in vivo tests to accomplish REACH legislation requirements for chemicals - a report by the transatlantic think tank for toxicology (t(4)). , 2009, ALTEX.

[14]  Robert Kavlock,et al.  The U.S. Environmental Protection Agency Strategic Plan for Evaluating the Toxicity of Chemicals , 2010, Journal of toxicology and environmental health. Part B, Critical reviews.

[15]  Thomas Hartung,et al.  The dawning of a new age of toxicology. , 2008, ALTEX.

[16]  R. S. Thomas,et al.  Approaches to developing alternative and predictive toxicology based on PBPK/PD and QSAR modeling. , 1998, Environmental health perspectives.

[17]  George Loizou,et al.  Characterizing uncertainty and variability in physiologically based pharmacokinetic models: state of the science and needs for research and implementation. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[18]  Thomas Hartung,et al.  Food for thought ... on globalisation of alternative methods. , 2007, ALTEX.

[19]  L. L. Smith,et al.  Key challenges for toxicologists in the 21st century. , 2001, Trends in pharmacological sciences.

[20]  Thomas Hartung,et al.  Food for thought ... on the evolution of toxicology and the phasing out of animal testing. , 2008, ALTEX.

[21]  F. Collins,et al.  Transforming Environmental Health Protection , 2008, Science.

[22]  Thomas Hartung,et al.  Chemical regulators have overreached , 2009, Nature.

[23]  Thomas Hartung,et al.  Barriers to Validation , 2008 .

[24]  T. Hartung,et al.  Alternatives to animal experimentation in basic research. , 2004, ALTEX.

[25]  T Seidle,et al.  The development of new concepts for assessing reproductive toxicity applicable to large scale toxicological programmes. , 2007, Current pharmaceutical design.

[26]  T. Hartung Toxicology for the twenty-first century , 2009, Nature.

[27]  Sebastian Hoffmann,et al.  Food for thought ... on in silico methods in toxicology. , 2009, ALTEX.

[28]  Thomas Hartung,et al.  Food for thought... on cell culture. , 2007, ALTEX.

[29]  Gianni Dal Negro,et al.  Barriers to validation: a report by the European Partnership fo Alternative Approaches to Animal Testing (EPAA) Working Group 5. , 2008, Alternatives to laboratory animals : ATLA.

[30]  T Hartung,et al.  Toward an evidence-based toxicology , 2006, Human & experimental toxicology.

[31]  Helmut Greim,et al.  Toxicological comments to the discussion about REACH , 2006, Archives of Toxicology.

[32]  Michael Balls [The three Rs: looking back ... and forward]. , 2005, ALTEX.

[33]  Coecke Sandra,et al.  Validation of Toxicogenomics-Based Test Systems:ECVAM-ICCVAM/NICEATM Considerations for Regulatory Use , 2006 .

[34]  Michael Balls,et al.  Guidance on Good Cell Culture Practice , 2005, Alternatives to laboratory animals : ATLA.

[35]  Sebastian Hoffmann,et al.  Diagnosis: toxic!--trying to apply approaches of clinical diagnostics and prevalence in toxicology considerations. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[36]  D Parent-Massin,et al.  Application of the CFU-GM assay to predict acute drug-induced neutropenia: an international blind trial to validate a prediction model for the maximum tolerated dose (MTD) of myelosuppressive xenobiotics. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[37]  J. Bailar,et al.  Toxicity Testing in the 21st Century: A Vision and a Strategy , 2010, Journal of toxicology and environmental health. Part B, Critical reviews.

[38]  Robert J. Kavlock The future of toxicity testing—The NRC vision and the EPA's ToxCast program national center for computational toxicology , 2009 .

[39]  T. Hartung,et al.  Food for thought ... On food safety testing. , 2008, ALTEX.

[40]  T Seidle,et al.  Bringing toxicology into the 21st century: a global call to action. , 2009, Toxicology in vitro : an international journal published in association with BIBRA.

[41]  Thomas Hartung,et al.  Food for thought... on the economics of animal testing. , 2009, ALTEX.

[42]  Melvin E. Andersen,et al.  The need for a new toxicity testing and risk analysis paradigm to implement REACH or any other large scale testing initiative , 2006, Archives of Toxicology.

[43]  C. Eskes,et al.  Alternative (non-Animal) Methods for Cosmetics Testing : Current Status and Future Prospects. A Report Prepared in the Context of the 7th Amendment to the Cosmetics Directive for Establishing the Timetable for Phasing Out Animal Testing , 2005 .

[44]  Andrew Worth,et al.  ECVAM's Response to the Changing Political Environment for Alternatives: Consequences of the European Union Chemicals and Cosmetics Policies , 2003, Alternatives to laboratory animals : ATLA.

[45]  Thomas Hartung,et al.  Are in vitro tests suitable for regulatory use? , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[46]  Christina Grindon,et al.  A review of the status of alternative approaches to animal testing and the development of integrated testing strategies for assessing the toxicity of chemicals under REACH--a summary of a DEFRA-funded project conducted by Liverpool John Moores University and FRAME. , 2006, Alternatives to laboratory animals : ATLA.

[47]  Harvey J Clewell,et al.  Development and specification of physiologically based pharmacokinetic models for use in risk assessment. , 2008, Regulatory toxicology and pharmacology : RTP.

[48]  Thomas Hartung,et al.  Food for thought... on evidence-based toxicology. , 2009, ALTEX.

[49]  B. Latour,et al.  Laboratory Life: The Construction of Scientific Facts , 1979 .

[50]  Robert J Kavlock,et al.  Toxicity Testing in the 21st Century: Implications for Human Health Risk Assessment , 2009, Risk analysis : an official publication of the Society for Risk Analysis.

[51]  Christina Rudén,et al.  The use of mechanistic data and the handling of scientific uncertainty in carcinogen risk assessments. The trichloroethylene example. , 2002, Regulatory toxicology and pharmacology : RTP.

[52]  T. Hartung Food for thought ... on validation. , 2007, ALTEX.

[53]  Raffaella Corvi,et al.  The carcinoGENOMICS project: critical selection of model compounds for the development of omics-based in vitro carcinogenicity screening assays. , 2008, Mutation research.

[54]  Hugh A Barton,et al.  Evaluation of physiologically based pharmacokinetic models for use in risk assessment , 2007, Journal of applied toxicology : JAT.

[55]  Thomas Hartung,et al.  Toward a New Toxicology — Evolution or Revolution? , 2008, Alternatives to laboratory animals : ATLA.

[56]  B. Blaauboer,et al.  Factors stimulating or obstructing the implementation of the 3Rs in the regulatory process. , 2007, ALTEX.

[57]  V. Rogiers,et al.  A review of national public funding programmes in European countries. , 2008, ALTEX.

[58]  Thomas Hartung,et al.  Food for thought ... on alternative methods for cosmetics safety testing. , 2008, ALTEX.

[59]  S. Bremer,et al.  The possible impact of human embryonic stem cells on safety pharmacological and toxicological assessments in drug discovery and drug development. , 2008, Current stem cell research & therapy.

[60]  Thomas Hartung,et al.  Meeting Report: Validation of Toxicogenomics-Based Test Systems: ECVAM–ICCVAM/NICEATM Considerations for Regulatory Use , 2005, Environmental health perspectives.

[61]  C. Grindon The fourth EC report on laboratory animal use--is it sufficiently revealing? , 2005, Alternatives to laboratory animals : ATLA.

[62]  Thomas Hartung,et al.  Workgroup Report: Incorporating In Vitro Alternative Methods for Developmental Neurotoxicity into International Hazard and Risk Assessment Strategies , 2007, Environmental health perspectives.

[63]  Robert Combes,et al.  Toxicity testing: creating a revolution based on new technologies. , 2005, Trends in biotechnology.

[64]  Melvin E Andersen,et al.  Toxicity testing in the 21st century: bringing the vision to life. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.